Special Reports
NSCLC (Issue 4)
Volume: 4
Issue: 1
Gynecologic Cancers (Issue 1)
Volume: 1
Issue: 1
Head and Neck Cancers (Issue 2)
Volume: 2
Issue: 1
Immunotherapy (Issue 3)
Volume: 3
Issue: 1
Gastrointestinal Cancers (Issue 2)
Volume: 2
Issue: 1
Head and Neck Cancers (Issue 1)
Volume: 1
Issue: 1
Hematologic Malignancies
Volume: 1
Issue: 1
NSCLC (Issue 3)
Volume: 3
Issue: 1
Precision Diagnostics
Volume: 1
Issue: 1
Melanoma (Issue 2)
Volume: 2
Issue: 1
Immunotherapy (Issue 2)
Volume: 2
Issue: 1
Gastrointestinal Cancers (Issue 1)
Volume: 1
Issue: 1
NSCLC (Issue 2)
Volume: 2
Issue: 1
Melanoma (Issue 1)
Volume: 1
Issue: 1
NSCLC (Issue 1)
Volume: 1
Issue: 1
Immunotherapy (Issue 1)
Volume: 1
Issue: 1
B-Cell Malignancies
Volume: 1
Issue: 1
Genitourinary Cancers
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5
